Overall, the median real world time on treatment for earliest olaparib monotherapy 4.6 months (95% CI 3.5 - 5.5), for patients with less than 3 lines of therapy was 5.3 months (95% CI 4.0 – 8.2), and ...
Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease progression after chemotherapy and radiation.
The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...
Lung cancer is preventable,” R.I. Health Director Jerry Larkin said. “Not smoking is the single most important thing people ...
The systemic agent is the first approved by the FDA for patients with NSCLC or pancreatic adenocarcinoma harboring an NRG1 gene fusion.
In one magical moment on Wednesday, Santa Claus worked with Princess Elsa of "Frozen" films to deliver a glorious wish to ...
Merus said the Food and Drug Administration approved Bizengri, the first treatment for adults diagnosed with pancreatic adenocarcinoma or non-small cell lung cancer that are advanced unresectable or ...
The 66th American Society of Hematology Annual Meeting & Exposition will take place December 7-10, 2024, in San Diego, ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
On June 14, Kate released her first remarks on her cancer treatment since revealing her diagnosis in March. She shared that she was "not out of the woods" with her treatment and that she still has "a ...
December is Lung Cancer Awareness Month. With lung cancer being the number one cause of death among cancer diagnoses, it’s ...
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback